This revised submission of the Clinical Trials Section of the Silvio O. Conte Neuroscience Center for the study of Glutamate Dysregulation in Schizophrenia has been enhanced by a new collaboration with Dr. Daniel Javitt. We will extend findings produced during the first five years and will examine possible explanations for the negative findings of our six month trial with D-cycloserine and the """"""""CONSIST"""""""" trial, a 4 month comparison of glycine and D-cycloserine-- neither found effects on negative symptoms or cognition. Because neither D-cycloserine nor glycine may adequing Dr. Javitt's IND, we will conduct a placebo-controlled trial of D-serine a glycine site partial agonist, did not produce siginificant improvement in negative or cognitive symptoms will be followed-up by a new approach in which D-cycloserine is administered once-weekly. This design is intended to avoid tolerance to repeated dosing with D-cycloserine; animal studies and recent studies in patients with phobia indicate that single doses substantially improve cognitive function, but that tolerance develops after approximately two weeks of daily dosing. We will conduct a trial of D-serine co-treatment. This study follows from a previous finding by Tsai and colleagues that the more potent, full agonist D-serine may be effective for positive, negative and cognitive symptoms without evidence for tolerance with repeated dosing. The recent completion of toxicology studies will allow us to obtain an IND for study of D-serine within the next year. In collaboration with Dr. Yurgelun- Todd, we will perform fMRI at baseline and week 8 of the D-serine trial to extend our previous finding of enhanced temporal lobe activation with D-cycloserine which correlated with improvement of negative symptoms. We will expand our collection of DNA samples and our extensive database of phenotypic information from 200 to 500 patients to allow examination of alleles relevant to glutamatergic regulation in relation to clinical characteristics and response to glutamatergic agents. Study of polymorphisms of G72 and D-amino acid oxidase as predictors of D-serine response is one example. We will also further pursue our studies of GCPII by examining two additional polymorphisms in a larger sample. In collaboration with Dr. Yurgelun-Todd, we will also examine NAA/NAAG concentrations in prefrental cortex as a potential biological marker of GCPII activity.

National Institute of Health (NIH)
National Institute of Mental Health (NIMH)
Specialized Center (P50)
Project #
Application #
Study Section
Special Emphasis Panel (ZMH1)
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
Mclean Hospital
United States
Zip Code
Dickie, Erin W; Ameis, Stephanie H; Shahab, Saba et al. (2018) Personalized Intrinsic Network Topography Mapping and Functional Connectivity Deficits in Autism Spectrum Disorder. Biol Psychiatry 84:278-286
Di Martino, Adriana; O'Connor, David; Chen, Bosi et al. (2017) Enhancing studies of the connectome in autism using the autism brain imaging data exchange II. Sci Data 4:170010
Wolosker, Herman; Balu, Darrick T; Coyle, Joseph T (2016) The Rise and Fall of the d-Serine-Mediated Gliotransmission Hypothesis. Trends Neurosci 39:712-721
Balu, Darrick T; Li, Yan; Takagi, Shunsuke et al. (2016) An mGlu5-Positive Allosteric Modulator Rescues the Neuroplasticity Deficits in a Genetic Model of NMDA Receptor Hypofunction in Schizophrenia. Neuropsychopharmacology 41:2052-61
Coyle, Joseph T; Balu, Darrick T; Puhl, Matthew D et al. (2016) History of the Concept of Disconnectivity in Schizophrenia. Harv Rev Psychiatry 24:80-6
Takagi, Shunsuke; Balu, Darrick T; Coyle, Joseph T (2015) Subchronic pharmacological and chronic genetic NMDA receptor hypofunction differentially regulate the Akt signaling pathway and Arc expression in juvenile and adult mice. Schizophr Res 162:216-21
Alaerts, Kaat; Nayar, Kritika; Kelly, Clare et al. (2015) Age-related changes in intrinsic function of the superior temporal sulcus in autism spectrum disorders. Soc Cogn Affect Neurosci 10:1413-23
Konopaske, Glenn T; Coyle, Joseph T (2015) Possible compensatory mechanisms for glutamatergic disconnection found in the auditory cortex in schizophrenia. Biol Psychiatry 77:923-4
Valk, Sofie L; Di Martino, Adriana; Milham, Michael P et al. (2015) Multicenter mapping of structural network alterations in autism. Hum Brain Mapp 36:2364-73
Ishiwata, Sayuri; Umino, Asami; Balu, Darrick T et al. (2015) Neuronal serine racemase regulates extracellular D-serine levels in the adult mouse hippocampus. J Neural Transm (Vienna) 122:1099-103

Showing the most recent 10 out of 128 publications